New wave of optimism for European biotech...The European biotech stock market witnessed an increase in IPO and follow-on financing volumes in 2017. According to the new BIOCOM capital market report, published in November during BIO-Europe in Berlin, … more ➔
European bioeconomy entering the next leve...A series of high-level conferences held in autumn and winter focused on current challenges to implementing an industrial scale bioeconomy in Europe. In November, the European Commission unveiled a new … more ➔
berlinconference, KMU New momentum for SMEsAntimicrobial resistance:?In 2017, the development of new drugs and diagnostics to combat multidrug-resistant pathogens gained momentum in Europe. Small and medium-sized companies (SMEs) successfully … more ➔
cancer genome, machine learning Cancer data: a dive into the depthsAs Big Data analytics begin to inspire medical decisionmaking, companies and scientists have gone to war over access to data derived from patient biopsies. Cancer profiling is a seminal situation. While … more ➔
pharmapackaging, phrmaceutical packaging Pharma packaging sector faces sea changePharmapack 2018 Focus:?The dawning age of digital healthcare is expected to transform the pharma packaging and drug delivery sector. At the 21st edition of Pharmapack Europe (7-8 February, 2018, Paris), … more ➔
KOLs see paradigm shift in the diagnosis a...Its still under the radar of analysts. However, the vasoactive peptide adrenomedullin could become the Next Big Thing in therapy monitoring and the treatment of disorders caused by endothelial dysfunction … more ➔
Hot guys in the pool rescue sustainabilityThe renewable energy sector is ramping up in a major way, but a host of infrastructure issues still need to be solved. One is that supply at times now outstrips demand, but theres no way to store excess … more ➔
Need a contemporary manufacturing strategy...Considering the high development costs of medications and the time invested before a drug goes from discovery to market, it is critical to develop not only a solid drug development strategy, but a contemporary … more ➔
The two faces of microgliaFor years, neurologists have hunted for the source of cell toxicity that drives neurodegeneration and cognitive decline in Alzheimers disease. An Indian researcher at the University of Zurich might … more ➔
Advanced formulations for biopharmaceutica...In the past, the role of customised and tailored formulations have been largely underestimated in the field of biopharmaceutical product development. An advanced formulation strategy can strongly improve … more ➔
